Strongyloides ratti: In vitro and in vivo activity of tribendimidine

PLoS Neglected Tropical Diseases

Volumn 2, Issue 1, 2008, Pages

  Keiser, Jennifer ^a   Thiemann, Kai ^a   Endriss, Yvette ^a   Utzinger, Jürg ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEMATODAL AGENT; IVERMECTIN; PHOSPHATE BUFFERED SALINE; TRIBENDIMIDINE; ANTHELMINTIC AGENT; PHENYLENEDIAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTHELMINTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EXPOSURE; IN VITRO STUDY; IN VIVO STUDY; INTESTINE PARASITE; MALE; NONHUMAN; RAT; SINGLE DRUG DOSE; STRONGYLOIDES RATTI; STRONGYLOIDIASIS; ANIMAL; DRUG EFFECT; LARVA; PARASITOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; ANTHELMINTICS; DOSE-RESPONSE RELATIONSHIP, DRUG; IVERMECTIN; LARVA; MALE; PHENYLENEDIAMINES; RATS; RATS, WISTAR; STRONGYLOIDES RATTI; STRONGYLOIDIASIS;

EID: 48949107725     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000136     Document Type: Article

References (26)

1. Bethony J, Brooker S, Albonico M, Geiger SM, Loukas A, et al. (2006) Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 367: 1521-1532.
2. Steinmann P, Zhou XN, Du ZW, Jiang JY, Wang LB, et al. (2007) Occurrence of Strongyloides stercoralis in Yunnan province, China, and comparison of diagnostic methods. PLoS Negl Trop Dis 1: e75. doi:10.1371/ journal.pntd.0000075.
3. Boulware DR, Stauffer WM, Hendel-Paterson BR, Rocha JL, Seet RC, et al. (2007) Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training survey. Am J Med 120: e1-8.
4. Keiser PB, Nutman TB (2004) Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 17: 208-217.
5. Hirata T, Kishimoto K, Kinjo N, Hokama A, Kinjo F, et al. (2007) Association between, Strongyloides stercoralis infection and biliary tract cancer. Parasitol Res 101: 1345-1348.
6. Utzinger J, Keiser J (2004) Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin Pharmacother 5: 263-285.
7. Shikiya K, Zaha O, Niimura S, Ikema M, Nakamura H, et al. (1992) Long term eradication rate of mebendazole therapy for strongyloidiasis. Kansenshogaku Zasshi 66: 354-359.
8. Satoh M, Kokaze A (2004) Treatment strategies in controlling strongyloidiasis. Expert Opin Pharmacother 5: 2293-2301.
9. Fox LM (2006) Ivermectin: uses and impact 20 years on. Curr Opin Infect Dig 19: 588-593.
10. Xiao SH, Wu HM, Tanner M, Utzinger J, Wang C (2005) Tribendimidine: a promising, safe and broad-spectrum anthelmintic agent from China. Acta Trop 94: 1-14.
11. Xiao SH, Wu ZX, Zhang J, Wang C (2007) Clinical observation on 899 children infected with intestinal nematodes and treated with tribendimidine enteric coated tablets: a phase IV clinical trial. Chin J Parasitol Para Dis (in press).
12. Keiser J, Xiao SH, Utzinger J (2006) Effect of tribendimidine on adult Echinostoma caproni harbored in mice, including scanning electron microscopic observations. J Parasitol 92: 858-862.
13. Keisi J, Xiao SH, Chollet J, Tanner M, Utzinger J (2007) Evaluation of the in vivo activity of tribendimidine against Schistosoma mansoni, Fasciola hepatica, Clonorchis sinensis and Opisthorchis viverrini. Antimicrob Agents Chemother 51: 1096-1098.
14. Garcia LS (2001) Diagnostic medical parasitology. Washington D.C.: ASM Press. pp 791.
15. Ren HN, Cheng BZ, Zhuang ZN (1987) Experimental therapeutic efficacy of a new anti-hookworm drug, tribendimidine. Chin J Parasitol Para Dis 5: 262-264.
16. Tobata-Kudo H, Kudo H, Tada I (2005) Strongyloides ratti: chemokinesis of glycolytic enzyme- and lectin-treated third-stage infective larvae in vitro. Parasitol Int 54: 147-152.
17. Rajasekariah GR, Deb BN, Dhage KR, Bose S (1986) Response of laboratory-adapted human hookworm and other nematodes to ivermectin. Ann Trop Med Parasitol 80: 615-621.
18. Grove DI (1983) The effects of 22,23-dihydroavermectin B1 on Strongyloides ratti and S. stercoralis infections in mice. Ann Trop Med Parasitol 77: 405-410.
19. Mojon M, Saura C, Roojee N, Tran Manh Sung R (1987) Albendazole and thiabendazole in murine strongyloidiasis. J Antimicrob Chemother 19: 79-85.
20. Grove DI (1982) Strongyloides ratti and S. stercoralis: the effects of thiabendazole, mebendazole, and cambendazole in infected mice. Am J Trop Med Hyg 31: 469-476.
21. Tomlinson G, Albuquerque CA, Woods RA (1985) The effects of amidantel (BAY d 8815) and its deacylated derivative (BAY d 9216) on Caenorhabditis elegans. Eur J Pharmacol 113: 255-262.
22. Horton J (2003) Human gastrointestinal helminth infections: are they now neglected diseases? Trends Parasitol 19: 527-531.
23. Keiser J, Utzinger J (2007) Advances in the discovery and development of trematocidal drugs. Expert Opin Drug Discov (in press).
24. von Samson-Himmelstjerna G, Harder A, Schnieder T, Kalbe J, Mencke N (2000) In vivo activities of the new anthelmintic depsipeptide PF 1022A. Parasitol Res 86: 194-199.
25. Harder A, von Samson-Himmelstjerna G (2001) Activity of the cyclic depsipeptide emodepside (BAY 44-4400) against larval and adult stages of nematodes in rodents and the influence on worm survival. Parasitol Res 87: 924-928.
26. Hotez PJ, Bethony J, Bottazzi ME, Brooker S, Diemert D, et al. (2006) New technologies for the control of human hookworm infection. Trends Parasitol 22: 327-331.